In declining to define CBD as a Generally Recognised as Safe (GRAS) ingredient this week, and sending warning letters to 15 companies selling products containing CBD, the US Food and Drug Administration has seemingly thrown the nascent CBD beverage category into doubt.
FDA must lead CBD out of the legal shadows – Comment
In declining to define CBD as a Generally Recognised as Safe (GRAS) ingredient this week, and sending warning letters to 15 companies selling products containing CBD, the US Food and Drug Administration has seemingly thrown the nascent CBD beverage category into doubt.